TY - JOUR
T1 - Blood pressure management through application-based telehealth platforms
T2 - a systematic review and meta-analysis
AU - Kalagara, Roshini
AU - Chennareddy, Susmita
AU - Scaggiante, Jacopo
AU - Matsoukas, Stavros
AU - Bhimani, Abhiraj
AU - Smith, Colton
AU - Putrino, David
AU - Dangayach, Neha S.
AU - Mocco, J.
AU - Schnipper, Jeffrey L.
AU - Auerbach, Andrew D.
AU - Kellner, Christopher P.
N1 - Funding Information:
N.S.D. has received funding from the Aneurysm and AVM Foundation, NCS Incline grant, Bee Foundation, Department of Neurosurgery Seed Grant, and the Freidman Brain Institute Pilot Grant. She is a part of the following clinical trials: Neurosteer (PI), DiyaHealth (PI), site PI ASTROH, Charm, Intrepid and ASPIRE. She is a consultant with Jacob's Institute. Her additional faculty/advisor appointments are as follows: SUNY Downstate, Department of Neurology; Lubin School of Business-Pace University, and the THRIVE program for SinaiBioDesign.
Funding Information:
J.L.S. received grant support from Mallinckrodt and the American Society of Health-System Pharmacists.
Funding Information:
A.D.A. receives grant funding from AHRQ, NHLBI and CDC and receives royalties as Editor of UpToDate.
Publisher Copyright:
© 2022 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2022/7/1
Y1 - 2022/7/1
N2 - Background and objectives: Hypertension management has several challenges, including poor compliance with medications and patients being lost to follow-up. Recently, remote patient monitoring and telehealth technologies have emerged as promising methods of blood pressure management. We aimed to investigate the role of application-based telehealth programs in optimizing blood pressure management. Methods: Searches were performed in December 2020 using three databases: Cochrane Central Register of Controlled Trials, Embase and Ovid MEDLINE. All randomized controlled trials that included remote blood pressure management programmes were eligible for inclusion. Studies were included if blood pressure data were available for both the intervention and control groups. Following PRISMA guidelines, data were independently collected by two reviewers. Data were pooled using a random-effects model. The primary study outcomes were mean SBP and DBP changes for the intervention and control groups. Results: Eight hundred and seventy-nine distinct articles were identified and 18 satisfied inclusion and exclusion criteria. Overall, a mean weighted decrease of 7.07 points (SBP) and 5.07 points (DBP) was found for the intervention group, compared with 3.11 point (SBP) and 3.13 point (DBP) decreases in the control group. Forest plots were constructed and effect sizes were also calculated. Mean change effect sizes of 1.1 (SBP) and 0.98 (DBP) were found, representing 86 and 85% of the intervention group having greater SBP or DBP changes, respectively, when compared with the control group. Discussion: Remote patient monitoring technologies may represent a promising avenue for hypertension management. Future research is needed to evaluate the benefits in different disease-based patient subgroups.
AB - Background and objectives: Hypertension management has several challenges, including poor compliance with medications and patients being lost to follow-up. Recently, remote patient monitoring and telehealth technologies have emerged as promising methods of blood pressure management. We aimed to investigate the role of application-based telehealth programs in optimizing blood pressure management. Methods: Searches were performed in December 2020 using three databases: Cochrane Central Register of Controlled Trials, Embase and Ovid MEDLINE. All randomized controlled trials that included remote blood pressure management programmes were eligible for inclusion. Studies were included if blood pressure data were available for both the intervention and control groups. Following PRISMA guidelines, data were independently collected by two reviewers. Data were pooled using a random-effects model. The primary study outcomes were mean SBP and DBP changes for the intervention and control groups. Results: Eight hundred and seventy-nine distinct articles were identified and 18 satisfied inclusion and exclusion criteria. Overall, a mean weighted decrease of 7.07 points (SBP) and 5.07 points (DBP) was found for the intervention group, compared with 3.11 point (SBP) and 3.13 point (DBP) decreases in the control group. Forest plots were constructed and effect sizes were also calculated. Mean change effect sizes of 1.1 (SBP) and 0.98 (DBP) were found, representing 86 and 85% of the intervention group having greater SBP or DBP changes, respectively, when compared with the control group. Discussion: Remote patient monitoring technologies may represent a promising avenue for hypertension management. Future research is needed to evaluate the benefits in different disease-based patient subgroups.
KW - blood pressure monitoring
KW - digital health
KW - remote patient monitoring
KW - telehealth
UR - http://www.scopus.com/inward/record.url?scp=85132956839&partnerID=8YFLogxK
U2 - 10.1097/HJH.0000000000003164
DO - 10.1097/HJH.0000000000003164
M3 - Review article
C2 - 35762467
AN - SCOPUS:85132956839
SN - 0263-6352
VL - 40
SP - 1249
EP - 1256
JO - Journal of Hypertension
JF - Journal of Hypertension
IS - 7
ER -